SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-23-242153
Filing Date
2023-09-26
Accepted
2023-09-26 12:43:42
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC TO-C d548797dsctoc.htm SC TO-C 13697
2 EX-99.1 d548797dex991.htm EX-99.1 42630
3 GRAPHIC g548797g0926183127974.jpg GRAPHIC 2476
4 GRAPHIC g548797g0926183128160.jpg GRAPHIC 2497
  Complete submission text file 0001193125-23-242153.txt   65051
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-87033 | Film No.: 231279448
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA RAGAZZI DEL 99 NO. 5 BOLOGNA L6 40133
Business Address VIA RAGAZZI DEL 99 NO. 5 BOLOGNA L6 40133 0039 0516489511
Alfasigma S.p.A. (Filed by) CIK: 0001994965 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6 | Fiscal Year End: 1231
Type: SC TO-C